(2R,3R,4S,5S,6S)-5-Amino-2-(((2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol xsulfate

Catalog No.: 
ACIRLE457
CAS No.: 
65710-07-8
Molecular Formula: 
C21H43N5O15S
Molecular Weight: 
637.66
(2R,3R,4S,5S,6S)-5-Amino-2-(((2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol xsulfate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$53.00In stockInquiry
25g95%$183.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5S,6S)-5-Amino-2-(((2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol xsulfate
IUPAC Name(2R,3R,4S,5S,6S)-5-amino-2-(((2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-(((1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)-4-hydroxy-3-(methylamino)octahydropyrano[3,2-b]pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diol sulfate
Molecular FormulaC21H43N5O15S
Molecular Weight637.66
SMILESO[C@H]1[C@@H](O[C@@H]2[C@@H](NC)[C@@H](O)[C@]3([H])[C@@](C[C@@H](N)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@H](N)C[C@@H]4N)O3)([H])O2)O[C@H](CO)[C@@H](N)[C@@H]1O.O=S(O)(O)=O
InChI KeyWGLYHYWDYPSNPF-RQFIXDHTSA-N
SynonymApramycin sulfate | 65710-07-8 | Apramycin sulphate | Apramycin (sulfate) | UNII-8UYL6NAZ3Q | 8UYL6NAZ3Q | AI3-29795 | EINECS 265-890-7 | 410097-64-2 | Apramycin, sulfate (2:5) | (+)-APRAMYCIN SULFATE | APRAMYCIN SULFATE (MART.) | APRAMYCIN SULFATE [MART.] | (2R,3R,4S,5S,6S)-2-[[(
CAS No.65710-07-8

Safety Data

Pictogram
Health hazard
Signal Word
Danger
Hazard Statement(s)
H360
Precautionary Statement(s)
P201-P308+P313

Comments (0)